Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2014; 20(39): 14132-14141
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14132
Table 2 Ongoing prospective randomized controlled trials in gastric cancer surgery
StudyCountryStart yearPhaseStudy designInclusionSample sizePrimary endpoint
KLASS-01South Korea2006IIILADG vs ODGcT1-2/N01400Overall survival
JCOG 0912Japan2010IIILADG vs ODGcT1-2/N0920Overall survival
JLSSG 0901Japan2010II/IIILADG vs ODGcT2-4a/N0-2/M0II: 180II: Morbidity
III: 500III: Relapse-free survival
KLASS-02South Korea2011IIILADG vs ODGcT2-4a/N0-4a/M010503-yr DFS
CLASS-01China2012IIILADG vs ODGcT2-4a/N0-4a/M010563-yr DFS
COACT 1001South Korea2010IIILADG vs ODGcT2-4a/N0-3a/M0204Noncompliance rate
KRGSSouth Korea2011IIRobot vs LaparoscopycT1-3/M01700Surgical outcomes
SENORITASouth Korea2012IIILaparoscopic SNNScT1-2/N0/size < 4 cm160Safety/efficacy